INTRODUCTION
The Wnt family of secreted proteins control embryogenesis, homeostasis, and regeneration, and Wnt signaling deregulation causes birth defects, cancer, osteoporosis, and other diseases (Clevers, 2006; Logan and Nusse, 2004; MacDonald et al., 2009; Moon et al., 2004) . As prototypic morphogens, Wnt proteins exhibit short-and long-range signaling properties in a concentration gradient field (Hausmann et al., 2007; Strigini and Cohen, 2000; Zecca et al., 1996) . Mechanisms that regulate Wnt biogenesis and gradient formation have not been fully defined. Critical for Wnt biogenesis/function are posttranslational modifications including N-glycosylation and lipidation, as best exemplified for mouse Wnt3a. O-acylation of serine 209 (S209) and N-glycosylation appear to be required for Wnt3a secretion (Komekado et al., 2007; Takada et al., 2006) , whereas palmitoylation of cysteine 77 (C77) is suggested to be important for Wnt3a activity (Willert et al., 2003) . These modifications have profound influence on Wnt exocytic trafficking, extracellular distribution, and/or receptor binding (Cong et al., 2004; Franch-Marro et al., 2008; Komekado et al., 2007; Kurayoshi et al., 2007; Takada et al., 2006; Willert et al., 2003; Zhai et al., 2004) . Whether Wnt proteins are posttranslationally modified and inactivated is unknown.
Canonical Wnt signaling plays a central role in anterior-posterior (AP) patterning (De Robertis and Kuroda, 2004; Niehrs, 2004; Petersen and Reddien, 2009) . Wnt engagement of receptors including the Frizzled (Fz) serpentine receptor and the singlespan LDL receptor-related protein 6 (LRP6) induces the stabilization of transcription coactivator b-catenin MacDonald et al., 2009) , thereby activating gene expression for AP patterning. In Xenopus embryos, an AP gradient of Wnt signaling occurs with the highest level posteriorly, and the dorsal Spemann-Mangold Organizer promotes head development via secreting Wnt antagonists such as secreted Fz-related proteins (sFRPs) and Dickkopf-1 (Dkk1), which bind to and inhibit Wnt/Fz or LRP6 to keep Wnt signaling low anteriorly (De Robertis and Kuroda, 2004; Harland and Gerhart, 1997; Niehrs, 2004) . Here we describe an Organizer-specific transmembrane protein, Tiki1, which is required for head formation via cleavage and inactivation of Wnt ligands.
RESULTS

Expression Cloning of Tiki1
We performed a functional cDNA expression screen in Xenopus embryos to identify genes involved in AP patterning/Wnt signaling. One isolated cDNA caused head enlargement and was named Tiki1 (Tiki refers to a large-headed humanoid in Polynesian mythology) ( Figure 1A ). Tiki1 encodes a type I transmembrane protein of 508 residues with an amino-terminal signal peptide, an ectodomain, and a transmembrane domain at the carboxyl terminus ( Figure 1B ). Tiki1 is the founding member of a conserved protein family, and a Tiki1 homolog is encoded in the genome of sponge Amphimedon queenslandica and sea anemone Nematostella vectensis and is likely in the common ancestor before invertebrates and vertebrates diverged ( Figure 1C and Figure S1 available online). Most vertebrates including Xenopus, zebrafish, and human have two genes, Tiki1 and Tiki2 ( Figures 1C and S1 ). Tiki proteins do not harbor known motifs but exhibit a conserved 340-residue ectodomain, referred to as the TIKI domain, which shares 25% identity/40% similarity with putative bacterial gumN proteins of unknown functions ( Figures 1C and S2A ).
Tiki1 Antagonizes Wnt Function
Head enlargement by Tiki1 overexpression phenocopies that by Dkk1 ( Figure 1A ), a Wnt/LRP6 antagonist . Indeed, Tiki1 antagonized Wnt function and inhibited axis duplication and induction of Xnr3 (a Wnt target gene) by Xenopus wnt8 (Xwnt8) but not by b-catenin or Dishevelled, another Wnt downstream component, and importantly not by a constitutively active LRP6DN (Figures 1D and 1E ). Thus Tiki1 likely acts at or upstream of Wnt receptors. Tiki1 did not affect signaling by secreted factors such as Nodal, a transforming growth factor-b (TGF-b) protein, or basic fibroblast growth factor (bFGF) ( Figures 1F and 1G ), attesting to its specificity. Xenopus Tiki2 and human TIKI1 and TIKI2 also behaved as Wnt antagonists in embryos (not shown), HEK293T cells (Figure S2B) , and mouse L cells (below). TIKI1N or TIKI2N, which is a secreted form of the respective ectodomain ( Figures 1B  and S1 ), was fully functional and interchangeable with TIKI1/2 in embryos (not shown) and cultured cells ( Figure S2C ).
Organizer Expression of Tiki1
RT-PCR revealed that Tiki1 messenger RNA (mRNA) becomes detectable at stage 9 and is prominently expressed from stage 10 (early gastrula) to stage 30 (tadpole) (Figure 2A ) and interestingly is restricted to the dorsal segment of the gastrula (Figure 2B) . At stage 10, Tiki1 is expressed exclusively in the dorsal blastopore lip, the Organizer, in a pattern similar to that of Dkk1 ( Figures 2C and 2D ). Longitudinal hemisectioning of the stage 10.5 embryo revealed that Tiki1 is excluded from the dorsal margin of the Organizer and overlapped with Dkk1 expression in the prechordal mesoderm and endomesoderm (Figures 2E and 2F) . At stage 11, Tiki1 and Dkk1 are expressed in the anterior prechordal plate (Figures 2G and 2H) . By blastopore closure, Tiki1 expression becomes distinct from that of Dkk1, as Tiki1 is restricted to the anterior midline, whereas Dkk1 displays a wing-shaped expression straddling Tiki1 (Figures 2I and 2J) . At early neurula, Tiki1 is expressed in the midline anterior to the tip of the notochord in cells of the endoderm and overlying neural ectoderm, whereas Dkk1 has a more broad expression pattern in the prospective ventral forebrain ( Figures 2K and 2L ). Thus Tiki1 is zygotically expressed in the Organizer, in particular in the head organizer region responsible for anterior patterning.
Organizer formation requires maternal Wnt signaling (De Robertis and Kuroda, 2004; Harland and Gerhart, 1997) . Ectopic Xwnt8 induced Tiki1 and Dkk1 expression ventrally, whereas Figure S1 ). TIKI domain is homologous to bacterial gumN (see Figure S2A) a dominant-negative TCF (T cell factor, a DNA-binding factor that mediates b-catenin signaling), DNTCF (Molenaar et al., 1996) , suppressed the endogenous Tiki1 and Dkk1 dorsal expression ( Figure 2M ). LiCl, which stabilizes b-catenin and thus dorsalizes embryos, induced Tiki1 and Dkk1 expression, whereas ultraviolet irradiation, which causes defective maternal Wnt signaling and ventralizes embryos, suppressed Tiki1 and Dkk1 expression ( Figure 2M ). Thus maternal Wnt signaling is necessary and sufficient for Tiki1 and Dkk1 expression in the Organizer.
Tiki1 Is Required for Head Development
We performed Tiki1 protein depletion using a Tiki1 morpholino antisense oligonucleotide (Tiki1MO), which specifically blocked the synthesis of the exogenously expressed Tiki1 (Tiki1-FLAG) in embryos ( Figure 3A ). Tiki1MO was unable to block the synthesis of HA*Tiki1, whose mRNA was engineered to lack the MO-targeting sequence, attesting to Tiki1MO specificity ( Figure 3A) . We injected 20 ng of Tiki1MO into two dorsal blastomeres of 8-cell stage embryos. Strikingly, roughly 50% of Tiki1MO-injected embryos developed anterior defects and exhibited loss of forebrain structures (including diminishment or loss of the cement gland and eyes) or cyclopic eyes fused at the midline ( Figures 3B and 3C ). HA*Tiki1 mRNA rescued Tiki1MO phenotypes ( Figures 3B and 3C ). Supporting a role of Tiki1 in Wnt inhibition during head formation, Dkk1 mRNA also rescued Tiki1MO anterior deficiency phenotypes ( Figure S3A ).
Tiki1MO suppressed the expression of head organizer genes including Goosecoid (Gsc), Lim1, Otx2, and Dkk1 in gastrula embryos (stages 10.5-11) ( Figure 3D and Table S1 ). Tiki1MO also inhibited the expression of Organizer gene Chordin but not of Organizer or dorsal genes Xnr3 and Xnot ( Figure 3D and Table S1 ), which are not involved in head organizer function. Tiki1MO reduced Gsc expression in the prechordal plate, the descendent of the head organizer, in neurula ( Figure S3B and Table S1 ). HA*Tiki1 mRNA rescued Tiki1MO effects on all head organizer genes examined ( Figure 3D and Table  S1 ). Control MO did not affect any marker examined ( Figure 3D and Table S1 ). Tiki1MO did not affect Gsc expression prior to stage 10.5 ( Figure S3C and Table S2 ), which relies on maternal Wnt signaling (Cho et al., 1991; Christian and Moon, 1993) . Thus Tiki1 is required for maintenance of the head organizer via antagonizing zygotic Wnt signaling. Consistent with this, Tiki1 inhibited Xwnt8 posterizing effect when both were expressed dorsally and zygotically via injected plasmids ( Figure S3D ).
Tiki1 expression/function in the head organizer implies its role in anterior-neural patterning. Tiki1MO injected into one dorsalanimal blastomere at the 8-cell stage suppressed at stage 16 the expression of forebrain markers BF1 and Otx2 and the midbrain marker En2, but not the posterior-neural marker Hoxb9, and HA*Tiki1 mRNA rescued the expression of BF1, Otx2, and En2 in Tiki1MO-injected embryos ( Figure S3E and Table S3 ). Therefore, Tiki1 is required for anterior-neural patterning.
TIKI Expression and Function in Human Cells
Tiki genes exhibit specific expression during embryogenesis ( Figure 2 and data not shown). We found, unexpectedly, that human HEK293T and HeLa cells, which are commonly used for Wnt signaling studies, express mRNAs for TIKI2 and TIKI1 plus TIKI2, respectively ( Figure 4A and data not shown). Depletion of TIKI2 in HEK293T cells via small interfering RNAs (siRNAs) enhanced Wnt3a-induced reporter expression by up to 7-fold ( Figure 4B ), and the enhancement levels correlated with the extent of reduction of TIKI2 mRNA and the tagged TIKI2 protein by the siRNAs ( Figures 4C and  S4A) ; furthermore, the TIKI2 siRNA effect was rescued by ectopic TIKI1 expression ( Figure 4D ). Thus the endogenous TIKI protein(s) acts to restrain Wnt signaling in cultured human cells.
Wnt Inactivation by Tiki Proteins
We investigated how Tiki antagonizes Wnt signaling. Upon expression in HEK293T or HeLa cells, Tiki1/TIKI1 and TIKI2 were detected at the plasma and internal membranes via imaging and surface biotinylation ( Figures 4E-4G ). We stably expressed TIKI2 in L cells or Wnt3a-expressing L cells (which expressed TIKI1 poorly ectopically). TIKI2 inhibited b-catenin stabilization in Wnt3a-producing cells ( Figure 4H , lanes 5 and 6) but apparently not in cells treated with Wnt3a conditioned media (CM) ( Figure 4H , lanes 3 and 4). Interestingly Wnt3a produced in L cells was secreted normally into CM in the presence of TIKI2 but exhibited faster electrophoretic migration prior to (in whole-cell lysates) and after secretion (in CM) (Figure 4I) . Similar results were observed for Wnt3a in HEK293T cells that coexpress TIKI1 or TIKI2 ( Figure S4B ). Wnt3a secreted from TIKI-expressing cells exhibited minimal activity, as it neither induced the Wnt-responsive reporter ( Figure 4J ) or phosphorylation of LRP6 and Dishevelled nor stabilized b-catenin ( Figure 4K ). Revealingly, Wnt3a secreted from TIKI2-expressing cells bound to neither Fz nor LRP6 ( Figure 4L ). Thus TIKI proteins result in a Wnt3a modification that minimizes Wnt3a activity but not secretion.
Elimination of Wnt Hydrophobicity by Tiki Proteins
Palmitoylation at C77 appears to be required for Wnt3a binding to Fz and LRP6, and the inactivity of Tiki-modified Wnt3a is reminiscent of Wnt3a(C77A), which harbors alanine substitution of C77 and lacks palmitoylation (Cong et al., 2004; Komekado et al., 2007; Willert et al., 2003) . In a detergent-aqueous phase separation assay, Wnt3a partitions in Triton X-114 detergent, whereas Wnt3a(C77A) is soluble aqueously (Komekado et al., 2007; Willert et al., 2003) . Wnt3a from TIKI1/2-expressing cells partitions exclusively in the aqueous phase (Figures 5A and S4C) , further resembling Wnt3a(C77A). Unexpectedly, metabolic labeling detected little difference in Wnt3a palmitate Figure S3 and Tables S1, S2, and S3.
incorporation with or without TIKI2 (Figures 5B and S4D) . Wnt3a(C77A), and in fact Wnt3a(C77A/S209A) that harbors alanine substitutions at both C77 and S209 and lacks lipidation at these two residues, were modified by TIKI2 as judged by electrophoretic mobility changes (Figures S4E and S4F) , and the residual autocrine signaling activity of Wnt3a(C77A) was inhibited by TIKI2 (Figure S4G) . TIKI2 also modified Wnt3a(N87Q/ N298Q), which has glutamine substitutions at the two glycosylated asparagines and lacks N-glycosylation (Komekado et al., 2007) (Figure S4F ). Thus despite elimination of Wnt3a hydrophobicity, Tiki modification of Wnt3a appears to be unrelated to C77 or S209 acylation or Nglycosylation.
Wnt Amino-Terminal Cleavage by Tiki Proteins
Wnt3a mutants deleted of the amino-terminal region were invariably resistant to Tiki modification ( Figure S4H ). Edman sequencing of TIKI2-modified Wnt3a revealed that eight amino-terminal residues, SYPIWWSL, had been removed from the mature Wnt3a (i.e., after signal peptide removal) ( Figure 5C ). A quantitative mass spectrometry (MS) approach was taken to further analyze this amino-terminal processing. Wnt3a was expressed alone or with TIKI2 in light or heavy stable isotope labeling by amino acids in cell culture (SILAC) medium (Ong et al., 2002) and analyzed for MS using FLEXIQuant quantification (Singh et al., 2009 (Singh et al., , 2012 (Figure S5A ). The relative peptide peak ratios of Wnt3a with and without TIKI2 confirmed cleavage of the eight residues in TIKI2-modified Wnt3a and also uncovered two additional cleavage sites of lesser abundance, which are seven and eight residues downstream of the main cleavage site ( Figures 5C, S5B , and S5C). The relative peptide peak ratios for the remaining Wnt3a with or without TIKI2 were largely unperturbed, suggesting that TIKI2 might not affect the rest of the Wnt3a protein ( Figure S5B and Table  S4 ). We generated HA-Wnt3a, which harbors the HA tag after the signal peptide. Remarkably, TIKI1 and TIKI2 resulted in removal of the HA epitope while leaving the rest of Wnt3a apparently intact ( Figure 5D ). The HA tag had no influence on Wnt3a cleavage by TIKI2 ( Figure S6A ). TIKI2 did not cleave the HA tag in HA-R-spondin1 (Rspo1; Wei et al., 2007) , a secreted Wnt agonist that harbors the HA tag after the signal peptide ( Figure 5E ). siRNA knockdown of the endogenous TIKI2 reduced the cleavage of HA-Wnt3a in HEK293T cells, as shown by increased retention of the HA epitope ( Figure 5F ).
Thus Tiki resulted in amino-terminal cleavage of Wnt3a (but not Rspo1), consistent with data from Edman sequencing and SILAC-FLEXIQuant analysis. To confirm TIKI cleavage specificity, we altered the two residues straddling the main (G) HeLa cells expressing HA-TIKI1 or HA-TIKI2 were treated with a nonpermeable biotinylation reagent. Cell surface (CS) proteins were precipitated with streptavidin beads and blotted for HA-TIKI1/2. WCL: input whole-cell lysates. The slower-migrating form of HA-TIKI, due possibly to glycosylation, was enriched on the cell surface. (H) TIKI2 inhibited b-catenin stabilization in Wnt3a-expressing cells. Indicated L cell lines were also treated with control or Wnt3a CM for 2 hr (lanes 1-4). b-tubulin: a loading control. (I) Wnt3a was secreted similarly with or without TIKI2 but exhibited faster migration due to TIKI2. (J) Wnt3a CM from TIKI2-expressing L cells exhibited minimal activity, tested at concentrations in 2-fold dilutions. (K) Wnt3a CM from TIKI2-expressing L cells induced minimal LRP6 or Dvl2 phosphorylation or b-catenin stabilization at 2 hr. LRP6 intensity reduction was not due to decreased protein levels but due to LRP6 phosphorylation, which perturbed recognition by the LRP6 antibody used (not shown). (L) Wnt3a secreted from TIKI2-expressing cells exhibited minimal binding to mFz8CRD-IgG or LRP6N-IgG (Tamai et al., 2000) . All error bars represent standard deviation (SD) in triplicates. See also Figure S4 . and minor cleavage sites in Wnt3a ( Figure 5C ). These HAWnt3a mutants, Wnt3a(S25D/L26D) and Wnt3a(S25D/L26D/ S33D/S34D), were partially and completely resistant to TIKI2 proteolysis, respectively ( Figure 5G, lanes 2, 4, and 6 ), demonstrating that TIKI2 acts through these residues. We then generated Wnt3aDN, which lacks the exact eight residues removed by TIKI2 ( Figure 5C ). Wnt3aDN was secreted normally but partitioned in the aqueous phase and exhibited minimal activity ( Figures 5H and 5I) , thereby behaving like Tiki-modified Wnt3a ( Figure 4J ). Therefore, Tiki promotes cleavage of the Wnt3a amino terminus, which has an essential role in Wnt3a activity. Supporting this notion, Wnt3a(S25D/L26D/S33D/S34D) was inactive despite secreting normally ( Figures S6B and S6C , the bottom panel).
Tiki Cleavage of Multiple Wnt Proteins
Tiki1/2 inhibits Xwnt8 in embryos (Figures 1 and S3D and data not shown). TIKI2 cleaved Xwnt8, as shown by removal of the amino-terminal HA tag (after the signal peptide) from HAXwnt8-FLAG, which also had a carboxy-terminal FLAG tag (Figure 5J) . MS analyses of Xwnt8-Myc or HA-Xwnt8-FLAG cleaved by TIKI2 suggested identically two amino-terminal cleavage sites, resulting in removal of 17 and 20 residues of mature Xwnt8, respectively ( Figure 5C and data not shown). TIKI2 also cleaved HA-Wnt5a at the amino terminus ( Figure 5K ). The low amount of Wnt5a production has hindered identification of the cleavage site(s). TIKI2 did not cleave HA-Xwnt11-FLAG (Figure 5L) , implying Wnt specificity.
Amino-terminal residues are highly variable among Wnt proteins despite conservation among paralogs in vertebrates. Consequently, TIKI2 cleavage sites in Wnt3a and Xwnt8 do not reveal recognizable consensus motifs ( Figure 5C ). To glimpse into this apparent paradox, we found that TIKI2, but not KRM2 (Kremen2; Mao et al., 2002) , bound to Wnt3a, Xwnt8, and Wnt5a but not Rspo1 ( Figures S6D-S6F and data not shown). This was not unanticipated given that enzymesubstrate pairs often show interaction. Intriguingly, TIKI2, but not KRM2, also bound to Xwnt11 ( Figure S6G ). We speculate that TIKI may interact with conserved motifs within Wnt proteins, thereby orientating itself for cleaving a specific Wnt amino terminus.
Tiki Is Probably a Metalloprotease TIKI2N was sufficient for Wnt3a inhibition and cleavage in cells (Figures 5, S2C, and S4) . We purified via a tandem affinity procedure recombinant TIKI2N, which upon in vitro incubation with purified HA-Wnt3a triggered Wnt3a cleavage and the HA disappearance ( Figures 5N and 5O) . KRM2N, which corresponds to the Kremen2 ectodomain, or TIKI2ND, a deletion mutant that lacks a TIKI-domain segment and neither modifies Wnt3a nor inhibits Wnt signaling in cells ( Figures 5M and S6H) , did not cleave HA-Wnt3a in vitro ( Figure 5O ). MS analyses of recombinant WNT3A cleaved by TIKI2N in vitro indicated cleavage at identical (major and minor) amino-terminal sites as observed in cells (data not shown). These results suggest that Tiki is, or is associated with, a Wnt protease.
We characterized TIKI protease activity in vitro. TIKI2N cleavage of HA-Wnt3a became obvious at 2 hr and exhibited preference for neutral to slightly basic pH (pH 7-9) ( Figures  S7A and S7B ). We applied protease inhibitors to survey which protease family TIKI belongs to. TIKI2N was sensitive neither to Bestatin, an aminopeptidase inhibitor, nor to a mixture of inhibitors for serine, cysteine, and aspartic proteases and aminopeptidases ( Figures 5P, S7C , and S7D). Remarkably, TIKI2N was inhibited by a metalloprotease inhibitor, 1,10-phenanthroline, which is a divalent metal chelator and was applied at concentrations 100-fold lower than recommended doses ( Figure 5P ). TIKI2N was also inhibited, albeit mildly, by EDTA, another metalloprotease inhibitor and divalent metal chelator ( Figure S7E ) (Barrett et al., 1998; Overall and Blobel, 2007) -dependent metalloprotease.
(C) Amino-terminal cleavage of Wnt3a and Xwnt8 by TIKI2. The big and small arrowheads indicate major and minor cleavage sites, respectively (see Figure S5 ). Wnt3aDN was engineered to be identical to TIKI-cleaved Wnt3a.
(D) TIKI cleaved the HA tag from HA-Wnt3a. TIKI1 cDNA was transfected at a 10-fold higher dose than that of TIKI2 for similar protein levels. See also Figures S4, S5 , S6, and S7 and Table S4 .
Wnt Oxidation-Oligomerization Induced by Tiki Cleavage Tiki-induced elimination of Wnt3a hydrophobicity (Figures 5A and S4C) was puzzling but intriguing. We unexpectedly found that Tiki-modified Wnt3a, but not control Wnt3a, existed in CM as large (>400 kDa) soluble oligomers, which were linked by intermolecular disulfide bonds and were massive in size, as a significant fraction showed minimal migration in gel ( Figure 6A ). This oxidized Wnt oligomerization was secondary to Tiki cleavage, as Wnt3aDN formed, without Tiki expression, similar large soluble oligomers that could be reduced ( Figure 6B ), as did Wnt3a(S25D/L26D/S33D/S34D), which is also inactive (Figure S6C) . Interestingly, oxidized Wnt3a oligomers partitioned exclusively aqueously, whereas monomeric (or noncovalently oligomeric) Wnt3a partitioned in detergent ( Figure 6C ), implying that lipid adducts may have been buried inside Wnt oligomers. Control Wnt3a exhibited traces of oxidized oligomers ( Figures  6A-6C ), which contained intact Wnt3a as demonstrated by the amino-terminal HA tag ( Figure S7F ). Thus Wnt3a may have intrinsic oxidation-oligomerization propensity, which the Wnt3a , and a common control lane was used. Secreted Wnt3a(C77A) after TIKI2 cleavage migrated slower in the reducing gel due to altered N-glycosylation (see Figure S4E) . (E) Wnt3a, Wnt3a(C77A), and Wnt3a(S209A) behaved similarly in whole-cell lysates. Each existed as monomers (arrow) and heterogeneous oxidized species from dimers (arrowhead) to larger oligomers (*), regardless of TIKI2 cleavage. See also Figures S6 and S7.
amino terminus acts to minimize. However, we cannot rule out that the trace amount of oxidized oligomers of control Wnt3a may be due to overexpression. Tiki-modified Wnt3a, Wnt3aDN, and Wnt3a(C77A) bare strong similarity in hydrophilic behavior and inactivity. Remarkably, Wnt3a(C77A) also formed oxidized oligomers in CM regardless of Tiki expression ( Figure 6D ). Although it is unknown whether these various oxidized Wnt3a oligomers were formed via disulfide bonds among the same cysteines, Wnt3a C77 palmitoylation may also be required for minimizing Wnt3a oxidationoligomerization, a role shared by the Wnt3a amino terminus that is removable by Tiki. However, whereas Tiki-modified Wnt3a and Wnt3aDN are severely impaired in autocrine and paracrine signaling ( Figures 4J, 5H , S2B, and S2C), Wnt3a(C77A) retains residual autocrine signaling activity (Figure S4G ) (Willert et al., 2003) , implying quantitative or qualitative differences in roles that the Wnt3a amino terminus and C77 palmitoylation play in maintaining Wnt3a activity.
We examined where Wnt oligomers were formed during biogenesis. Surprisingly, in whole-cell lysates, there was little difference among Wnt3a, Wnt3a(C77A), and Wnt3a(S209A), regardless of TIKI2 cleavage: each existed as monomers (or noncovalent oligomers) and heterogeneous oxidized oligomers from likely dimers to larger multimers ( Figure 6E ). These results may be consistent with our suspicion that during biogenesis, Wnt3a has intrinsic oxidizing propensity, which is minimized by the Wnt3a amino terminus and C77 palmitoylation during/after secretion, leaving only traces of oxidized oligomers in CM. But for TIKI-cleaved Wnt3a or Wnt3a(C77A), this propensity may be exacerbated during/after secretion, resulting in massive oxidized oligomers in CM. Wnt3a(S209A) was not secreted as reported ( Figure S7G ) (Takada et al., 2006) .
Tiki Can Act in Both Wnt-Producing and Wnt-Responding Cells
Cellular localization ( Figures 4E-4G) suggests that Tiki may act on secretory and plasma membranes. Consistent with both scenarios, Tiki1N ( Figure S2C ) and Tiki1N-KDEL, which harbors the ER-retention KDEL sequence at the Tiki1N carboxyl terminus and was hardly secreted (Figure S7H ), each potently inhibited Wnt signaling ( Figure S6H ). Tiki showed inhibition in Wntproducing cells but apparently not in Wnt-responding cells ( Figure 4H ). We were concerned, however, that excessive Wnt3a added acutely might have activated signaling prior to, or overwhelmed, Tiki function. We thus investigated this issue under more physiological settings in embryos. We performed Wnt-responsive reporter assays via Tiki overexpression or knockdown. First, we injected two animal blastomeres separately with Xwnt8 mRNA or S01234-luciferase DNA ( Figure 7A ), which is driven by the promoter of the Siamois gene, a direct Wnt target (Brannon et al., 1997) . Animal blastomeres were chosen as their progenies do not express Tiki1 (Figure 2 ). Xwnt8 induced expression of the reporter ( Figure 7A ) but not of S0-luciferase in which TCF-binding sites were mutated (Brannon et al., 1997 ) (data not shown). Coinjection of Xwnt8 with Tiki1, but not LDLR, inhibited the reporter ( Figure 7A ). Thus Tiki1 could inhibit Wnt activity in Wnt-producing cells as seen in mammalian cells. We then altered the coinjection scheme by injecting Xwnt8 in one blastomere and injecting Tiki1 (or LDLR) mRNA plus S01234-luciferase in a neighboring blastomere ( Figure 7B ). Tiki1, but not LDLR, inhibited Xwnt8-induced reporter in Wntresponding cells ( Figure 7B) .
We addressed the same question complementarily via Tiki1MO knockdown in dorsal blastomeres whose progenies express Tiki1 endogenously. We coinjected an Xwnt8 plasmid (transcribing Xwnt8 after mid-blastula transition) plus Tiki1MO or control MO into a blastomere (i.e., to knock down Tiki1 in Xwnt8-producing cells) and injected S01234-luciferase into the neighboring blastomere ( Figure 7C ). Alternatively, we injected the Xwnt8 plasmid into a single blastomere and coinjected S01234-luciferase plus Tiki1MO or control MO into the neighboring blastomere (i.e., to knock down Tiki1 in Xwnt8-responding cells; Figure 7D ). Xwnt8 induced S01234-luciferase, but not S0-luciferase, and the Xwnt8 response was enhanced by Tiki1MO under either condition ( Figures 7C and 7D ), Thus the endogenous Organizer Tiki1 acts in both Wnt-producing and Wnt-responding cells.
We further monitored how Tiki1 inhibits Wnt-induced nuclear b-catenin accumulation. We injected Xwnt8 plus red fluorescent protein (RFP) mRNA into an animal blastomere and injected Tiki1 or LDLR mRNA plus fluorescein dextran (FLD) into a neighboring blastomere ( Figure 7E ). Thus, Xwnt8-expressing cells were RFP + (red), whereas Wnt-responding cells that expressed Tiki1 or LDLR were FLD + (green), and naive cells from uninjected blastomeres lacked either fluorescence ( Figures 7G, 7H , 7K, and 7L). Nuclear b-catenin (blue) was observed at stage 9 in Xwnt8-expressing cells (red) due to autocrine signaling (arrows, Figure 7I ) and in cells that expressed LDLR (green) in response to Xwnt8 (arrowheads, Figure 7I ). By contrast, much fewer Tiki1-expressing cells (green, Figure 7K ) exhibited nuclear b-catenin (arrowheads, Figure 7M ). Quantification showed 75% of LDLRexpressing and naive cells versus 30% of Tiki1-expressing cells displaying nuclear b-catenin ( Figure 7F ), supporting that Tiki1 functions in Wnt-responding cells. We propose that Tiki functions in Wnt-producing cells by acting in the secretory pathway and at the plasma membrane and in Wnt-responding cells by acting at the plasma membrane.
DISCUSSION
We identified a family of Tiki proteins that inactivate Wnt morphogens through proteolytic cleavage. Tiki1 is expressed in the Spemann-Mangold Organizer and is required for head formation in Xenopus embryos. In the absence of Tiki1, expression of all head organizer genes examined is diminished, resulting in defective head organizer function, which in turn causes deficiency in anterior-neural patterning. Tiki1 appears to be required for Organizer maintenance, which is antagonized by zygotic Wnt signaling, but not for initiation of Organizer formation, which requires maternal Wnt signaling. Tiki1 as a founding ''Wnt inactivator'' thus joins known Organizer-specific Wnt antagonists such as Dkk1 and Frzb/sFRP3 and acts to ensure a ''Wnt-free'' zone for anteriorization. Tiki1 functions in both Wnt-producing and Wnt-responding cells, thereby inactivating Wnt proteins made by the Organizer or by neighboring or posterior regions. Organizer Tiki1 expression is induced by maternal Wnt signaling, reflecting a negative feedback loop that is common in morphogen signaling. Tiki-mediated Wnt inactivation may exist before the split of invertebrate and vertebrate lineages, as a Tiki homolog is encoded in the genome of sponge Amphimedon and of sea anemone Nematostella. Tiki proteins share homology with putative bacterial gumN proteins of )-dependent metalloprotease that cleaves the amino terminus of Wnt proteins, despite baring no recognizable homology to known proteases. TIKI2 cleaves Wnt3a, Xwnt8, and Wnt5a but not Xwnt11, implying broad yet stringent Wnt specificity. Wnt amino-terminal residues are conserved among vertebrate paralogs but are highly variable among nonparalogs, as such TIKI2 cleavage sites in Wnt3a and Xwnt8 do not reveal a recognizable consensus. As TIKI2 interacts with each tested Wnt including Xwnt11, TIKI may bind to a conserved motif within Wnt proteins and then cleave Wnt amino termini selectively. Tiki neither inhibits signaling by Nodal/TGF-b or bFGF nor cleaves Rspo1. Importantly, TIKI fails to cleave a Wnt3a mutant with missense alterations at the proteolytic sites, further reflecting selectivity for peptide bond hydrolysis.
Tiki cleavage results in Wnt3a oxidation and oligomerization through inter-Wnt disulfide bond formation. These soluble Wnt3a oligomers exhibit drastically altered biophysical and biochemical properties including the loss of hydrophobicity and of receptor binding, which are fully recapitulated by Wnt3aDN. Thus the Wnt amino terminus has a critical role in preventing Wnt oxidation-oligomerization, a feature exploited by Tiki1 during anterior patterning. This feature may also relate to Wnt lipid modifications, which are exemplified by Wnt3a C77 palmitoylation and S209 acylation and have distinct roles in Wnt biogenesis/function. S209 acylation is essential for Wnt3a secretion (Takada et al., 2006) due to its involvement in Wnt3a binding to the Wntless transporter (Bä nziger et al., 2006; Coombs et al., 2010) . Wnt3a C77 palmitoylation is suggested to be required for activity but not secretion (Willert et al., 2003) via an as-yet unclear mechanism. Our study suggests a potential link between C77 and/or its palmitoylation and Wnt folding. Wnt3a(C77A), which lacks palmitoylation and is commonly used in Wnt studies, shows behaviors similar to those of Tikimodified Wnt3a/Wnt3aDN, as they are all hydrophilic and inactive and form in CM oxidized oligomers, which in fact may explain why each fails to bind to Fz or LRP6. We do not discount that C77 palmitoylation and the Wnt3a amino terminus may be involved in binding to both Fz and LRP6 simultaneously, but such a scenario appears to be more convoluted. Therefore, C77 palmitoylation, like the Wnt3a amino terminus, is likely required for keeping Wnt3a from oxidation-oligomerization during biogenesis. A recent study shows that a mutant Drosophila Wingless (Wg) protein, Wg C93A , which has an alanine substitution at C93 (equivalent to Wnt3a C77), is secreted but forms large-sized (>1.3M Dalton) soluble aggregates (Mulligan et al., 2012) . Although it is to be determined whether Wg aggregates are formed by inter-Wg disulfide bonds like Wnt3a(C77A) oligomers, a conserved role of palmitoylation in preventing oligomerization may be shared between Wg and Wnt3a. We caution, however, that Wnt3a(C77A) or Wg C93A is only a surrogate for, but not identical to, Wnt3a or Wg lacking palmitoylation. We note that although oxidized Wnt3a oligomers are inactive, our findings do not exclude the possibility that active Wnt3a proteins are noncovalent oligomers or monomers.
Oxidized oligomers formed by Tiki-modified Wnt3a or Wnt3a(C77A), which harbors dual lipids or a single lipid, are soluble aqueously (Willert et al., 2003 ; this study) and in fact exhibit strict correlation with hydrophilic behavior, in sharp contrast to Wnt3a monomers. Thus, these inactive Wnt oligomers are unlikely to be misfolded/denatured aggregates but rather may represent an alternative conformation that buries the lipid(s) inside, thereby exhibiting hydrophilic behaviors. It is intriguing how Tiki removal of eight amino-terminal residues, which do not contain a cysteine, exacerbates inter-Wnt3a oxidation, which seems to be prevalent during biogenesis ( Figure 6E ). Among important questions are the specificity and mechanism of Tiki1/2 toward Wnt proteins, whether Tiki cleavage regulates noncanonical Wnt pathways, how the Wnt amino terminus and palmitoylation maintain Wnt in the active state, and whether oxidized Wnt oligomers, given the reversible nature of oxidation, can be reduced/functionally reactivated by reducing enzymes or disulfide isomerases. Our study of Wnt cleavage by Tiki has uncovered an additional dimension of Wnt regulation that depends on unsuspected but critical Wnt biogenic properties. As Wnt signaling plays essential roles in diseases including cancer and osteoporosis, TIKI1/2 as likely Wnt-proteolytic enzymes may represent potential therapeutic targets.
EXPERIMENTAL PROCEDURES
Xenopus Embryo Manipulations and cDNA Library Screening Procedures for embryo manipulation, reverse transcription PCR, and in situ hybridization were performed as previously described (Tamai et al., 2000) . The Arrayed Xenopus tropicalis full-length cDNAs (Voigt et al., 2005) were used for the screening as performed previously (Kato et al., 2002) . cDNA pools (in the CS107 vector) that contain 96 independent clones were transcribed in vitro using SP6 polymerase, and the resulting mRNA pools were injected into the dorsal side of the embryo at 4-cell stage at the dose of 10 ng RNA/embryo. Injected embryos were scored at stages 30-31 for enlarged or diminished anterior development. The positive pools were divided into smaller pools, and the same process was repeated till a single cDNA was identified.
Morpholino Injection
To examine Tiki1MO specificity, 500 pg Tiki1-FLAG (targeted by MO) or HA*Tiki1 (resistant to MO) were injected with or without the Tiki1MO (5, 10, 20, 40 ng) into the animal pole at the 2-cell stage, and animal caps were dissected at stage 10 for western blotting. To knockdown the endogenous Tiki1, 20 ng of control MO, Tiki1MO, or Tiki1MO together with 50 pg of HA*Tiki1 mRNA were injected into two dorsal blastomeres at the 8-cell stage, and the phenotype was scored at stage 42.
Cell Culture, Transfection, and Reporter Assay HEK293T, HeLa, L, and L-Wnt3a cells (from ATCC) were maintained in Dulbecco's modified Eagle's medium (DMEM; Invitrogen) supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin-glutamine (Invitrogen). Lipofectamine 2000 (Invitrogen) or Fugene6 (Roche) was used for all cell transfections. L and L-Wnt3a cells that stably express TIKI2 were generated by infecting cells with retroviruses and selected by puromycin. L cells stably expressing Wnt3a(FLAG) were established by transfecting L cells with a Wnt3a(FLAG)-expressing vector and selected with neomycine. L cells stably expressing both Wnt3a(FLAG) and TIKI2 were also generated. TOPFLASH reporter assay was performed as previously described (MacDonald et al., 2008) .
RNAi
To knockdown human TIKI2 in the TOPFLASH reporter assay, HEK293T cells in 24-well plates were transfected with 100 ng of TOPFLASH reporter, 5 ng of TK-Renilla reporter, 5 ng of empty vector or Wnt3a, and 20 nM of each siRNA. The reporter activities were examined 48 hr post-transfection. To examine the cleavage of Wnt3a by endogenous TIKI2, 150 ng of HA-Wnt3a was transfected together with 20 nM of each siRNA into HEK293T cells in a 12-well plate, and after 48 hr, the resulting CM were analyzed by western blotting with anti-HA and anti-Wnt3a antibodies.
In Vitro Treatment of Wnt3a with Purified Proteins About 50 ng purified TIKI2N, KRM2N, or TIKI2ND protein was mixed with 10 ng purified HA-Wnt3a in a total volume of 10 ml HEPES buffer (50 mM HEPES [pH 7.4], 100 mM NaCl, 0.2% NP-40) and incubated at 30 C for 12 hr. To examine TIKI2N activity in different pH conditions, the following buffer was used instead of HEPES, 100 mM sodium acetate (pH 5.5), 100 mM 7, 8, 9) , or 50 mM CAPS (pH 10, 11), and the reaction was incubated for 4 hr. To examine the effect of inhibitors on TIKI2N activity, the inhibitors (dissolved in DMSO) were added in the reaction system for 4 hr, and DMSO was used as a negative control. To examine the effect of divalent metals, 50 mM of each divalent metal ion was applied in the in vitro reaction and incubated for 2 hr. To rescue TIKI2N activity with divalent metals after inhibition with 1, 10-Phenanthroline, 20 mM of 1, 10-Phenanthroline was first applied in the in vitro reaction for 1 hr, and 50 mM of each metal ion was added and incubated for another 2 hr. The reaction product was analyzed by SDS-PAGE and western blotting with anti-HA and anti-Wnt3a antibodies. For MS analysis, 200 ng of recombinant WNT3A (from Stem RD) was incubated with about 500 ng of TIKIN or KRM2N overnight at 30 C and separated by SDS-PAGE. The WNT3A bands were cut, trypsin digested, and subjected to MS analyses.
ACCESSION NUMBERS
Sequences of human TIKI1 and TIKI2, Xenopus Tiki1 and Tiki2, zebrafish Tiki1 and Tiki2, C. elegans Tiki, Nematostella Tiki, and Amphimedon Tiki have been deposited in GenBank under accession numbers JQ653415, JQ653416, JQ653417, JQ653418, JQ653419, JQ653420, JQ653421, JQ653422, and JQ653423, respectively.
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